US Edition
CroíValve secures funding from Horizon Europe EIC Accelerator - Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
€18.75 million funding recommended for two Enterprise Ireland client companies in Horizon Europe EIC Accelerator | Manufacturing & Supply Chain
Two Enterprise Ireland-backed companies have won funding approvals of up to €18.75 million in the latest competition under Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. The two successful companies are CroíValve and Lios. Enterprise Ireland leads the National Support Network for Horizon Europe which helps entrepreneurs to compete and win funding in EIC competitions. To date, 28 Irish companies have secured approvals t…
CroíValve secures funding from Horizon Europe EIC Accelerator - Cardiovascular News
CroíValve, developer of the Duo transcatheter system for the treatment of tricuspid regurgitation (TR), has been awarded funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. Part of the EU’s Horizon Europe 2021–2027 Research and Innovation programme, the EIC Accelerator Programme provides funding to high-potential, high-risk start-ups, scale-ups and subject matter experts. This award includes grant funding of €2…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
